Literature DB >> 29325492

Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus.

K Nowicka-Sauer1, A Hajduk2, H Kujawska-Danecka2, D Banaszkiewicz3, Ż Smoleńska2, Z Czuszyńska2, J Siebert1.   

Abstract

Objectives Illness perception is a cognitive representation influencing physical and psychological functioning and adherence in patients with rheumatic disease. Studies exploring illness perception in systemic lupus erythematosus (SLE) are still scarce and none of them have investigated factors determining illness perception. We aimed to assess illness perception and to identify psychological, clinical and sociodemographic factors that might influence illness perception in SLE. Methods The study involved 80 patients with SLE (87.5% women, mean age 41.56 years). The Brief Illness Perception Questionnaire, State Trait Anxiety Inventory, Beck Depression Inventory, Pittsburgh Sleep Quality Index, Visual Analogue Scale-Pain and Fatigue Severity Scale were used. Clinical and sociodemographic data were collected via structured interview and medical files review. Results Illness perception was significantly positively correlated with anxiety, depression, sleep quality, fatigue and pain while it was not related to age, education, steroid treatment, disease duration and activity (SLEDAI) or organ damage (SLICC/ACR). Regression analysis revealed that state anxiety and depression explained 43% of illness perception variance. Cluster analysis identified three patient groups among which the middle-aged group had the most negative illness perception, the highest levels of anxiety, depression, pain and fatigue, and the poorest sleep quality. Conclusions The study has proved a significant relationship between negative illness perception and anxiety and depression. Patients reporting fatigue, poor sleep and pain might have special needs in terms of psychological intervention focused on negative illness perception and distress symptoms. Multidisciplinary care in managing SLE seems to be of great importance.

Entities:  

Keywords:  B-IPQ; Systemic lupus erythematosus; anxiety; depression; illness perception

Mesh:

Year:  2018        PMID: 29325492     DOI: 10.1177/0961203317751858

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

Review 1.  Anxiety and Mood Disorders in Systemic Lupus Erythematosus: Current Insights and Future Directions.

Authors:  Annaliese Tisseverasinghe; Christine Peschken; Carol Hitchon
Journal:  Curr Rheumatol Rep       Date:  2018-11-12       Impact factor: 4.592

2.  Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis.

Authors:  Domenico Paolo Emanuele Margiotta; Alice Laudisio; Luca Navarini; Fabio Basta; Carmen Mazzuca; Silvia Angeletti; Massimo Ciccozzi; Raffaele Antonelli Incalzi; Antonella Afeltra
Journal:  Clin Rheumatol       Date:  2019-01-28       Impact factor: 2.980

3.  Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life.

Authors:  Elena Elefante; Chiara Tani; Chiara Stagnaro; Viola Signorini; Beatrice Lenzi; Dina Zucchi; Francesca Trentin; Linda Carli; Francesco Ferro; Marta Mosca
Journal:  Front Med (Lausanne)       Date:  2022-03-29

4.  Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.

Authors:  Elena Elefante; Chiara Tani; Chiara Stagnaro; Francesco Ferro; Alice Parma; Linda Carli; Viola Signorini; Dina Zucchi; Umberto Peta; Adele Santoni; Leonardo Raffaelli; Marta Mosca
Journal:  RMD Open       Date:  2020-02

5.  Effects of illness perceptions on health-related quality of life in patients with rheumatoid arthritis in China.

Authors:  Juan Wang; Zhe Yang; Yan Zheng; Yaling Peng; Qing Wang; Hongli Xia; Yan Wang; Jin Ding; Ping Zhu; Lei Shang; Zhaohui Zheng
Journal:  Health Qual Life Outcomes       Date:  2021-04-20       Impact factor: 3.186

6.  Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study.

Authors:  Myrto Nikoloudaki; Argyro Repa; Sofia Pitsigavdaki; Ainour Molla Ismail Sali; Prodromos Sidiropoulos; Christos Lionis; George Bertsias
Journal:  J Clin Med       Date:  2022-07-25       Impact factor: 4.964

Review 7.  State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases.

Authors:  Leopoldo Trieste; Sara Cannizzo; Ilaria Palla; Isotta Triulzi; Giuseppe Turchetti
Journal:  Front Med (Lausanne)       Date:  2022-09-23

8.  Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study.

Authors:  Yoshia Miyawaki; Sayaka Shimizu; Yusuke Ogawa; Ken-Ei Sada; Yu Katayama; Yosuke Asano; Keigo Hayashi; Yuriko Yamamura; Sumie Hiramatsu-Asano; Keiji Ohashi; Michiko Morishita; Haruki Watanabe; Mariko Takano-Narazaki; Yoshinori Matsumoto; Nobuyuki Yajima; Ryusuke Yoshimi; Yasuhiro Shimojima; Shigeru Ohno; Hiroshi Kajiyama; Kunihiro Ichinose; Shuzo Sato; Michio Fujiwara; Hajime Yamazaki; Yosuke Yamamoto; Jun Wada; Shunichi Fukuhara
Journal:  Arthritis Res Ther       Date:  2021-03-10       Impact factor: 5.156

9.  Impact of depressive disorders on quality of life after middle ear surgery in patients with chronic otitis media.

Authors:  Susen Lailach; Theresa Langanke; Thomas Zahnert; Susan Garthus-Niegel; Marcus Neudert
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-03       Impact factor: 2.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.